This Stock Has Room To Run
Analysts believe this stock's product demand could rise quickly in the next few years.
Click here now for all the details.

PSTX Insider Trading

Insider Ownership Percentage: 29.20%
Insider Buying (Last 12 Months): $8,024,999.50
Insider Selling (Last 12 Months): $592,968.24

Poseida Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Poseida Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Poseida Therapeutics Share Price & Price History

Current Price: $4.10
Price Change: Price Increase of +0.05 (1.23%)
As of 03/22/2023 09:34 AM ET

This chart shows the closing price history over time for PSTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Poseida Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/8/2022Eric OstertagChairmanBuy142,857$3.50$499,999.50838,824View SEC Filing Icon  
8/8/2022Life Sciences Holdings L MalinMajor ShareholderBuy2,150,000$3.50$7,525,000.0011,835,673View SEC Filing Icon  
8/3/2022Eric OstertagChairmanSell160,696$3.69$592,968.24695,967View SEC Filing Icon  
3/16/2022Kerry D. IngallsCOOBuy3,000$3.98$11,940.00View SEC Filing Icon  
12/6/2021Life Sciences Holdings L MalinDirectorBuy1,828$6.90$12,613.20View SEC Filing Icon  
12/1/2021Life Sciences Holdings L MalinDirectorBuy18,365$6.85$125,800.25View SEC Filing Icon  
11/29/2021Life Sciences Holdings L MalinDirectorBuy11,057$6.89$76,182.73View SEC Filing Icon  
11/26/2021Life Sciences Holdings L MalinDirectorBuy27,251$6.81$185,579.31View SEC Filing Icon  
11/23/2021Life Sciences Holdings L MalinDirectorBuy14,625$6.77$99,011.25View SEC Filing Icon  
11/18/2021Life Sciences Holdings L MalinDirectorBuy71,312$7.18$512,020.16View SEC Filing Icon  
11/17/2021Kerry D. IngallsCOOBuy2,000$7.00$14,000.00View SEC Filing Icon  
11/16/2021Life Sciences Holdings L MalinDirectorBuy27,680$7.17$198,465.60View SEC Filing Icon  
11/8/2021Eric OstertagCEOSell18,924$7.09$134,171.16View SEC Filing Icon  
10/1/2021Eric OstertagCEOSell20,029$7.02$140,603.58View SEC Filing Icon  
9/20/2021Eric OstertagCEOSell20,000$8.00$160,000.00View SEC Filing Icon  
9/14/2021Eric OstertagCEOSell20,000$8.14$162,800.00View SEC Filing Icon  
8/20/2021Matthew A. SpearInsiderSell4,000$8.79$35,160.0045,485View SEC Filing Icon  
7/1/2021Eric OstertagCEOSell20,563$9.77$200,900.51View SEC Filing Icon  
6/11/2021Matthew A. SpearInsiderSell4,000$9.44$37,760.0020,485View SEC Filing Icon  
6/1/2021Eric OstertagCEOSell41,194$8.61$354,680.34542,985View SEC Filing Icon  
5/3/2021Eric OstertagCEOSell18,326$9.01$165,117.26542,985View SEC Filing Icon  
4/21/2021Matthew A. SpearInsiderSell4,000$8.44$33,760.0015,485View SEC Filing Icon  
4/5/2021Eric OstertagCEOSell57,819$9.66$558,531.54542,985View SEC Filing Icon  
4/1/2021Eric OstertagCEOSell57,181$9.55$546,078.55542,985View SEC Filing Icon  
2/16/2021Eric OstertagCEOSell133,149$10.00$1,331,490.00431,590View SEC Filing Icon  
2/10/2021Eric OstertagCEOSell12,389$10.00$123,890.00431,590View SEC Filing Icon  
1/21/2021Eric OstertagCEOSell4,462$10.00$44,620.00364,056View SEC Filing Icon  
7/14/2020Sean MurphyDirectorBuy10,000$16.00$160,000.0010,000View SEC Filing Icon  
See Full Table
Stocks Positioned For The Year
This breakthrough stock has bright future this decade.
Learn more today.

SEC Filings (Institutional Ownership Changes) for Poseida Therapeutics (NASDAQ:PSTX)

46.67% of Poseida Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PSTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Poseida Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/16/2023State of Wyoming7,146$38K0.0%N/A0.008%Search for SEC Filing on Google Icon
2/15/2023Jane Street Group LLC70,353$0.37M0.0%N/A0.082%Search for SEC Filing on Google Icon
2/15/2023Lazard Asset Management LLC16,944$89K0.0%N/A0.020%Search for SEC Filing on Google Icon
2/15/2023Virtu Financial LLC17,789$94K0.0%N/A0.021%Search for SEC Filing on Google Icon
2/15/2023Silverarc Capital Management LLC2,230,000$11.82M3.4%-12.7%2.595%Search for SEC Filing on Google Icon
2/15/2023Susquehanna Fundamental Investments LLC10,447$55K0.0%N/A0.012%Search for SEC Filing on Google Icon
2/15/2023Millennium Management LLC1,646,897$8.73M0.0%+984.9%1.916%Search for SEC Filing on Google Icon
2/15/2023Morgan Stanley106,087$0.56M0.0%+52.7%0.123%Search for SEC Filing on Google Icon
2/15/2023Man Group plc27,663$0.15M0.0%+130.2%0.032%Search for SEC Filing on Google Icon
2/15/2023EAM Investors LLC218,305$1.16M0.2%N/A0.254%Search for SEC Filing on Google Icon
2/15/2023Atom Investors LP33,175$0.18M0.1%-78.2%0.039%Search for SEC Filing on Google Icon
2/15/2023Boothbay Fund Management LLC17,142$91K0.0%N/A0.020%Search for SEC Filing on Google Icon
2/14/2023Verition Fund Management LLC13,500$72K0.0%N/A0.016%Search for SEC Filing on Google Icon
2/14/2023683 Capital Management LLC36,966$0.20M0.0%N/A0.043%Search for SEC Filing on Google Icon
2/14/2023Marshall Wace LLP511,404$2.71M0.0%N/A0.595%Search for SEC Filing on Google Icon
2/14/2023Two Sigma Investments LP66,185$0.35M0.0%+115.0%0.077%Search for SEC Filing on Google Icon
2/14/2023Penserra Capital Management LLC28,590$0.15M0.0%-60.1%0.033%Search for SEC Filing on Google Icon
2/13/2023Charles Schwab Investment Management Inc.264,577$1.40M0.0%+2.0%0.308%Search for SEC Filing on Google Icon
2/13/2023Callan Capital LLC62,347$0.33M0.0%N/A0.073%Search for SEC Filing on Google Icon
2/13/2023Barclays PLC58,109$0.31M0.0%+84.7%0.068%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC196,300$1.04M0.0%-42.8%0.228%Search for SEC Filing on Google Icon
2/13/2023Geode Capital Management LLC491,472$2.60M0.0%+8.0%0.572%Search for SEC Filing on Google Icon
2/13/2023GSA Capital Partners LLP95,469$0.51M0.1%N/A0.111%Search for SEC Filing on Google Icon
2/13/2023Knott David M Jr168,839$0.90M0.3%+11.6%0.196%Search for SEC Filing on Google Icon
2/13/2023JPMorgan Chase & Co.31,224$0.17M0.0%-72.4%0.036%Search for SEC Filing on Google Icon
2/10/2023Bank of America Corp DE18,696$99K0.0%-28.9%0.022%Search for SEC Filing on Google Icon
2/10/2023Creative Planning10,800$57K0.0%-46.8%0.013%Search for SEC Filing on Google Icon
2/10/2023HRT Financial LP200,351$1.06M0.0%N/A0.233%Search for SEC Filing on Google Icon
2/10/2023Blair William & Co. IL19,143$0.10M0.0%+8.5%0.022%Search for SEC Filing on Google Icon
2/9/2023Dimensional Fund Advisors LP276,419$1.47M0.0%+128.6%0.322%Search for SEC Filing on Google Icon
2/9/2023Citigroup Inc.163,675$0.87M0.0%+5,651.1%0.190%Search for SEC Filing on Google Icon
2/1/2023Bank of Montreal Can399,472$1.62M0.0%-22.9%0.465%Search for SEC Filing on Google Icon
1/31/2023MCF Advisors LLC42,854$0.23M0.0%-17.4%0.050%Search for SEC Filing on Google Icon
12/8/2022Bank of New York Mellon Corp49,468$0.18M0.0%+181.7%0.058%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Investments LP30,777$0.11M0.0%N/A0.036%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.2,384,866$8.42M0.0%+79.9%2.775%Search for SEC Filing on Google Icon
11/15/2022Perceptive Advisors LLC750,000$2.65M0.1%N/A0.873%Search for SEC Filing on Google Icon
11/15/2022EcoR1 Capital LLC2,650,000$9.36M0.3%N/A3.083%Search for SEC Filing on Google Icon
11/15/2022Bank of New York Mellon Corp49,468$0.18M0.0%+181.7%0.058%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.1,447,918$5.11M0.0%+29.7%1.685%Search for SEC Filing on Google Icon
11/14/2022Pentwater Capital Management LP5,975,000$21.09M0.2%+20.3%7.222%Search for SEC Filing on Google Icon
11/14/2022Cormorant Asset Management LP1,850,000$6.53M0.5%N/A2.236%Search for SEC Filing on Google Icon
11/14/2022Cubist Systematic Strategies LLC15,510$55K0.0%N/A0.019%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC343,300$1.21M0.0%-9.7%0.415%Search for SEC Filing on Google Icon
11/14/2022Ergoteles LLC93,842$0.33M0.0%-31.2%0.113%Search for SEC Filing on Google Icon
11/14/2022Penserra Capital Management LLC71,587$0.25M0.0%N/A0.087%Search for SEC Filing on Google Icon
11/14/2022Crown Advisors Management Inc.150,000$0.53M0.5%N/A0.181%Search for SEC Filing on Google Icon
11/14/2022Forefront Analytics LLC15,650$59K0.0%-33.0%0.019%Search for SEC Filing on Google Icon
11/10/2022Dimensional Fund Advisors LP120,943$0.43M0.0%-16.6%0.146%Search for SEC Filing on Google Icon
11/10/2022Bank of Montreal Can517,900$2.10M0.0%N/A0.626%Search for SEC Filing on Google Icon
11/9/2022MCF Advisors LLC51,854$0.18M0.0%-13.1%0.063%Search for SEC Filing on Google Icon
11/8/2022Atom Investors LP152,120$0.54M0.2%+172.5%0.184%Search for SEC Filing on Google Icon
11/4/2022Prudential Financial Inc.12,600$44K0.0%N/A0.015%Search for SEC Filing on Google Icon
11/2/2022DekaBank Deutsche Girozentrale80,000$0.26M0.0%N/A0.097%Search for SEC Filing on Google Icon
10/28/2022Silverarc Capital Management LLC2,554,277$9.02M3.0%+571.1%3.088%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.44,715$0.12M0.0%-20.8%0.054%Search for SEC Filing on Google Icon
8/16/2022Corton Capital Inc.14,978$39K0.0%-74.2%0.018%Search for SEC Filing on Google Icon
8/16/2022Delphia USA Inc.15,799$41K0.0%-61.2%0.019%Search for SEC Filing on Google Icon
8/15/2022State Street Corp92,967$0.24M0.0%-82.5%0.112%Search for SEC Filing on Google Icon
8/15/2022Citadel Advisors LLC72,574$0.19M0.0%+156.1%0.088%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP545,700$1.41M0.0%N/A0.660%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC1,012,515$2.61M0.0%+21.3%1.224%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC380,100$0.98M0.0%+103.3%0.606%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp50,246$0.13M0.0%-79.0%0.080%Search for SEC Filing on Google Icon
8/12/2022FMR LLC9,405,708$24.27M0.0%+0.3%11.369%Search for SEC Filing on Google Icon
8/11/2022JPMorgan Chase & Co.234,184$0.60M0.0%-26.5%0.373%Search for SEC Filing on Google Icon
8/10/2022Forefront Analytics LLC23,370$61K0.0%-12.7%0.037%Search for SEC Filing on Google Icon
7/25/2022Silverarc Capital Management LLC380,606$0.98M0.3%+58.8%0.607%Search for SEC Filing on Google Icon
5/23/2022Cantor Fitzgerald L. P.30,205$0.14M0.0%+19.8%0.048%Search for SEC Filing on Google Icon
5/17/2022Delphia USA Inc.40,733$0.18M0.1%N/A0.065%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.56,477$0.25M0.0%-27.5%0.090%Search for SEC Filing on Google Icon
5/16/2022State Street Corp531,573$2.38M0.0%-2.3%0.850%Search for SEC Filing on Google Icon
5/16/2022Prelude Capital Management LLC11,250$50K0.0%N/A0.018%Search for SEC Filing on Google Icon
5/13/2022Silverarc Capital Management LLC239,696$1.07M0.4%+2.0%0.383%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC187,000$0.84M0.0%+456.5%0.299%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp239,289$1.07M0.0%-5.0%0.383%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.220,090$0.99M0.0%+3.9%0.352%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.1,446,264$6.48M0.0%-0.4%2.312%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP144,567$0.65M0.0%+48.5%0.231%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.2,468,954$11.06M0.0%-3.3%3.947%Search for SEC Filing on Google Icon
5/12/2022Martingale Asset Management L P16,116$73K0.0%-32.0%0.026%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.318,676$1.43M0.0%+7.0%0.509%Search for SEC Filing on Google Icon
5/9/2022Forefront Analytics LLC26,770$0.12M0.0%+152.1%0.043%Search for SEC Filing on Google Icon
5/5/2022MCF Advisors LLC57,469$0.26M0.0%N/A0.092%Search for SEC Filing on Google Icon
5/5/2022Russell Investments Group Ltd.9,407$42K0.0%-66.6%0.015%Search for SEC Filing on Google Icon
4/29/2022Nisa Investment Advisors LLC13,000$58K0.0%N/A0.021%Search for SEC Filing on Google Icon
4/19/2022Regent Investment Management LLC20,922$94K0.0%-16.3%0.033%Search for SEC Filing on Google Icon
2/14/2022Blair William & Co. IL48,963$0.33M0.0%N/A0.078%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP84,701$0.58M0.1%N/A0.136%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp251,793$1.72M0.0%-2.0%0.403%Search for SEC Filing on Google Icon
2/2/2022New York State Common Retirement Fund11,972$82K0.0%-42.1%0.019%Search for SEC Filing on Google Icon
1/21/2022Russell Investments Group Ltd.28,178$0.19M0.0%-25.2%0.045%Search for SEC Filing on Google Icon
1/18/2022Central Bank & Trust Co.7,608$52K0.0%+1,579.5%0.012%Search for SEC Filing on Google Icon
11/17/2021Altium Capital Management LP32,238$0.24M0.1%N/A0.052%Search for SEC Filing on Google Icon
11/16/2021Schonfeld Strategic Advisors LLC289,179$2.11M0.0%+13.6%0.463%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC909,856$6.63M0.0%-13.0%1.456%Search for SEC Filing on Google Icon
11/15/2021Pura Vida Investments LLC114,343$0.83M0.0%-20.1%0.183%Search for SEC Filing on Google Icon
11/15/2021Voya Investment Management LLC13,813$0.10M0.0%-87.9%0.022%Search for SEC Filing on Google Icon
11/15/2021Martingale Asset Management L P15,615$0.11M0.0%N/A0.025%Search for SEC Filing on Google Icon
11/12/2021Trexquant Investment LP12,442$91K0.0%N/A0.020%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Poseida Therapeutics logo
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; and P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, ovarian, and other epithelial-derived cancers. In addition, the company engages in the development of P-CD19CD20-ALLO1 for B cell malignancies and other autoimmune diseases; and P-BCMACD19-ALLO1, an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for multiple myeloma. Further, it is developing P-PSMA-ALLO1, an allogeneic CAR-T product candidate for treating mCRPC. Additionally, the company engages in the development of P-OTC-101 and P-FVIII-101 that are clinical stage liver-directed gene therapies; and other allogeneic dual CAR candidates. It has a research collaboration and license agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2014 and is headquartered in San Diego, California.
Read More on Poseida Therapeutics

Today's Range

Now: $4.10
Low: $4.10
High: $4.10

50 Day Range

MA: $6.40
Low: $3.89
High: $8.73

52 Week Range

Now: $4.10
Low: $1.82
High: $8.82

Volume

242 shs

Average Volume

624,204 shs

Market Capitalization

$354.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.37

Who are the company insiders with the largest holdings of Poseida Therapeutics?

Poseida Therapeutics' top insider shareholders include:
  1. Life Sciences Holdings L Malin (Major Shareholder)
  2. Eric Ostertag (Chairman)
  3. Eric Ostertag (CEO)
  4. Matthew A Spear (Insider)
  5. Kerry D Ingalls (COO)
  6. Life Sciences Holdings L Malin (Director)
Learn More about top insider investors at Poseida Therapeutics.

Who are the major institutional investors of Poseida Therapeutics?

Poseida Therapeutics' top institutional investors include:
  1. Silverarc Capital Management LLC — 2.59%
  2. Millennium Management LLC — 1.92%
  3. Marshall Wace LLP — 0.60%
  4. Geode Capital Management LLC — 0.57%
  5. Bank of Montreal Can — 0.46%
  6. Dimensional Fund Advisors LP — 0.32%
Learn More about top institutional investors of Poseida Therapeutics stock.

Which institutional investors are selling Poseida Therapeutics stock?

Within the previous quarter, PSTX stock was sold by these institutional investors:
  1. Silverarc Capital Management LLC
  2. Renaissance Technologies LLC
  3. Atom Investors LP
  4. Bank of Montreal Can
  5. JPMorgan Chase & Co.
  6. Penserra Capital Management LLC
  7. Creative Planning
  8. MCF Advisors LLC

Which institutional investors are buying Poseida Therapeutics stock?

In the previous quarter, PSTX stock was purchased by institutional investors including:
  1. Millennium Management LLC
  2. Marshall Wace LLP
  3. EAM Investors LLC
  4. HRT Financial LP
  5. Citigroup Inc.
  6. Dimensional Fund Advisors LP
  7. GSA Capital Partners LLP
  8. Jane Street Group LLC
Within the last year, these company insiders have bought Poseida Therapeutics stock:
  1. Life Sciences Holdings L Malin (Major Shareholder)
  2. Eric Ostertag (Chairman)
  3. Eric Ostertag (CEO)
  4. Matthew A Spear (Insider)
Learn More investors buying Poseida Therapeutics stock.
Lithium Could Be 2023's Next Big Surprise
Lithium is the hottest commodity for our green future
Click here for complete free report